Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis

References

• WhitcherJSrinivasanMUpadhyayMCorneal blindness: A global perspectiveBull World Health Organ200179321422111285665
   PubMed Web of Science ®Google Scholar
• DandonaLDandonaRNaduvilathTIs current eye-care-policy focus almost exclusively on cataract adequate to deal with blindness in India?Lancet19983519112131213169643793
   PubMed Web of Science ®Google Scholar
• LevinLAveryRShoreJWoogJBakerAThe spectrum of orbital aspergillosis: A clinicopathological reviewSurv Ophthalmol19964121421548890440
   PubMed Web of Science ®Google Scholar
• YohaiRBullockJAzizAMarkertRSurvival factors in rhino-orbital-cerebral mucormycosisSurv Ophthalmol19943913227974189
   PubMed Web of Science ®Google Scholar
• SeeJWongTYeoKTrends in the pattern of blindness and major ocular diseases in Singapore and AsiaAnn Acad Med Singapore19982745405469791663
   PubMedGoogle Scholar
• HaganMWrightENewmanMDolinPJohnsonGCauses of suppurative keratitis in GhanaBr J Ophthalmol19957911102410288534648
   PubMed Web of Science ®Google Scholar
• PuttannaSPrimary keratomycosisJ All India Ophthalmol Soc19691751712004914371
   PubMedGoogle Scholar
• GalarretaDTuftSRamsayADartJFungal keratitis in London: Microbiological and clinical evaluationCornea20072691082108617893539
   PubMed Web of Science ®Google Scholar
• SrinivasanMFungal keratitisCurr Opin Ophthalmol200415432132715232472
   PubMedGoogle Scholar
• BhartiyaPDaniellMConstantinouMIslamFTaylorHFungal keratitis in MelbourneClin Experiment Ophthalmol200735212413017362452
   PubMed Web of Science ®Google Scholar
• NelsonPEDignaniMCAnaissieEJTaxonomy, biology, and clinical aspects of Fusarium speciesClin Microbiol Rev1994744795047834602
   PubMed Web of Science ®Google Scholar
• ThomasPMycotic keratitis – an underestimated mycosisJ Med Vet Mycol19943242352567983569
   PubMedGoogle Scholar
• GopinathanUGargPFernandesMSharmaSAthmanathanSRaoGThe epidemiological features and laboratory results of fungal keratitis: A 10-year review at a referral eye care center in South IndiaCornea200221655555912131029
   PubMed Web of Science ®Google Scholar
• RosaRMillerDAlfonsoEThe changing spectrum of fungal keratitis in south FloridaOphthalmology19941016100510138008340
   PubMed Web of Science ®Google Scholar
• CueroRGEcological distribution of Fusarium solani and its opportunistic action related to mycotic keratitis in Cali, ColombiaJ Clin Microbiol19801234554617217337
   PubMed Web of Science ®Google Scholar
• StevensDKanVJudsonMPractice guidelines for diseases caused by aspergillus. Infectious Diseases Society of AmericaClin Infect Dis200030469670910770732
   PubMed Web of Science ®Google Scholar
• TabbaraKal JabartiAHospital construction-associated outbreak of ocular aspergillosis after cataract surgeryOphthalmology199810535225269499785
   PubMed Web of Science ®Google Scholar
• SmolinGFosterCSAzarDTDohlmanCHThe Cornea: Scientific Foundations and Clinical Practice4th edPhiladelphia, PALippincott Williams & Wilkins Inc.2005
   Google Scholar
• KlintworthGThe cornea – structure and macromolecules in health and disease. A reviewAm J Pathol1977893718808339743
   PubMed Web of Science ®Google Scholar
• ThomasPACurrent perspectives on ophthalmic mycosesClin Microbiol Rev200316473079714557297
   PubMed Web of Science ®Google Scholar
• GordonMNortonSCorneal transplant infection by Paecilomyces lilacinusSabouraudia19852342953013901331
   PubMedGoogle Scholar
• KozarskyAStultingRWaringGCornellFWilsonLCavanaghHPenetrating keratoplasty for exogenous Paecilomyces keratitis followed by postoperative endophthalmitisAm J Ophthalmol19849855525576541878
   PubMed Web of Science ®Google Scholar
• FincherRFisherJLovellRNewmanCEspinel-IngroffAShadomyHInfection due to the fungus Acremonium (cephalosporium)Medicine (Baltimore)19917063984091956281
   PubMed Web of Science ®Google Scholar
• GuarroJGamsWPujolIGeneJAcremonium species: New emerging fungal opportunists – in vitro antifungal susceptibilities and reviewClin Infect Dis1997255122212299402385
   PubMed Web of Science ®Google Scholar
• GargPGopinathanUChoudharyKRaoGKeratomycosis: Clinical and microbiologic experience with dematiaceous fungiOphthalmology2000107357458010711898
   PubMed Web of Science ®Google Scholar
• JonesBPrinciples in the management of oculomycosis. XXXI Edward Jackson memorial lectureAm J Ophthalmol19757957197511096622
   PubMed Web of Science ®Google Scholar
• SternGButtrossMUse of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal diseaseOphthalmology19919868478531866135
   PubMed Web of Science ®Google Scholar
• HariprasadSMMielerWFLinTKSponselWEGraybillJRVoriconazole in the treatment of fungal eye infections: A review of current literatureBr J Ophthalmol200892787187818577634
   PubMed Web of Science ®Google Scholar
• FairleyCSullivanTBartleyPAllworthTLewandowskiRSurvival after rhino-orbital-cerebral mucormycosis in an immunocompetent patientOphthalmology2000107355555810711895
   PubMed Web of Science ®Google Scholar
• MarshallDBrownsteinSJacksonWMintsioulisGGilbergSal-ZeerahBPost-traumatic corneal mucormycosis caused by Absidia corymbiferaOphthalmology19971047110710119224461
   PubMed Web of Science ®Google Scholar
• Mino de KasparHZoulekGParedesMMycotic keratitis in ParaguayMycoses1991345–62512541795722
   PubMed Web of Science ®Google Scholar
• PandaASharmaNDasGKumarNSatpathyGMycotic keratitis in children: Epidemiologic and microbiologic evaluationCornea19971632952999143801
   PubMed Web of Science ®Google Scholar
• TanureMCohenESudeshSRapuanoCLaibsonPSpectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, PennsylvaniaCornea200019330731210832689
   PubMed Web of Science ®Google Scholar
• SrinivasanMGonzalesCAGeorgeCEpidemiology and aetiological diagnosis of corneal ulceration in Madurai, south IndiaBr J Ophthalmol199781119659719505820
   PubMed Web of Science ®Google Scholar
• SonyPSharmaNVajpayeeRRayMTherapeutic keratoplasty for infectious keratitis: A review of the literatureCLAO J200228311111812144228
   PubMedGoogle Scholar
• DunlopAWrightEHowladerSSuppurative corneal ulceration in Bangladesh. A study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitisAust N Z J Ophthalmol19942221051107917262
   PubMedGoogle Scholar
• WongTNgTFongKTanDRisk factors and clinical outcomes between fungal and bacterial keratitis: A comparative studyCLAO J19972342752819348453
   PubMedGoogle Scholar
• ClinchTRobinsonMBarronBInslerMLiangKKaufmanHFungal keratitis from nylon line lawn trimmersAm J Ophthalmol199211444374401415454
   PubMed Web of Science ®Google Scholar
• OkhraviNDartJKTowlerHMLightmanSPaecilomyces lilacinus endophthalmitis with secondary keratitis: A case report and literature reviewArch Ophthalmol199711510132013249338682
   PubMedGoogle Scholar
• ManzouriBVafidisGWyseRPharmacotherapy of fungal eye infectionsExpert Opin Pharmacother20012111849185711825321
   PubMedGoogle Scholar
• FlorCruzNVPeczonIJrMedical interventions for fungal keratitisCochrane Database Syst Rev2008CD00424118254043
   PubMed Web of Science ®Google Scholar
• O’DayDSelection of appropriate antifungal therapyCornea1987642382453319407
   PubMed Web of Science ®Google Scholar
• KhooSHBondJDenningDWAdministering amphotericin B – a practical approachJ Antimicrob Chemother19943322032138182001
   PubMed Web of Science ®Google Scholar
• BatesDSuLYuDMortality and costs of acute renal failure associated with amphotericin B therapyClin Infect Dis200132568669311229835
   PubMed Web of Science ®Google Scholar
• O’DayDHeadWRobinsonRClantonJCorneal penetration of topical amphotericin B and natamycinCurr Eye Res19865118778823490954
   PubMed Web of Science ®Google Scholar
• O’BrienTPTherapy of ocular fungal infectionsOphthalmol Clin North Am1999123350
   Google Scholar
• Natacyn [Package insert]Alcon Laboratories Inc.Texas52008
   Google Scholar
• PandaASharmaNAngraSTopical fluconazole therapy of Candida keratitisCornea19961543733758776563
   PubMed Web of Science ®Google Scholar
• SealDPleyerUOcular Infection and Immunity2nd edNew York, NYInforma Healthcare Inc.2007
   Google Scholar
• GanegodaNRaoSKAntifungal therapy for keratomycosesExpert Opin Pharmacother20045486587415102569
   PubMed Web of Science ®Google Scholar
• O’DayDHeadWRobinsonRWilliamsTGeddeSAnomalous effect of subconjunctival miconazole on Candida albicans keratitis in rabbitsAm J Ophthalmol199111255625661951595
   PubMed Web of Science ®Google Scholar
• TorresMAMohamedJCavazos-AdameHMartinezLATopical ketoconazole for fungal keratitisAm J Ophthalmol198510022932984025470
   PubMed Web of Science ®Google Scholar
• FosterCSLassJHMoran-WallaceKGiovanoniROcular toxicity of topical antifungal agentsArch Ophthalmol1981996108110846263236
   PubMed Web of Science ®Google Scholar
• FosterCSStefanyszynMIntraocular penetration of miconazole in rabbitsArch Ophthalmol197997917031706475641
   PubMedGoogle Scholar
• ThomasPAFungal infections of the corneaEye (Lond)200317885286214631389
   PubMed Web of Science ®Google Scholar
• PrajnaNVJohnRKNirmalanPKLalithaPSrinivasanMA randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitisBr J Ophthalmol200387101235123714507756
   PubMed Web of Science ®Google Scholar
• AvundukABeuermanRWarnelEKaufmanHGreerDComparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitisCurr Eye Res200326211311712815530
   PubMed Web of Science ®Google Scholar
• NuneryWWelshMSaylorRPseudallescheria boydii (Petriellidium boydii) infection of the orbitOphthalmic Surg19851652963004011116
   PubMedGoogle Scholar
• Sonego-KroneSSanchez-Di MartinDAyala-LugoRClinical results of topical fluconazole for the treatment of filamentous fungal keratitisGraefes Arch Clin Exp Ophthalmol2006244778278716133016
   PubMed Web of Science ®Google Scholar
• TuEAlternaria keratitis: Clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofunginCornea200928111611919092423
   PubMed Web of Science ®Google Scholar
• LauDFedinandsMLeungLPenetration of voriconazole, 1%, eyedrops into human aqueous humor: A prospective open-label studyArch Ophthalmol2008126334334618332313
   PubMedGoogle Scholar
• RaoSMadhavanHRaoGPadmanabhanPFluconazole in filamentous fungal keratitisCornea19971667009395885
   PubMed Web of Science ®Google Scholar
• RajasekaranJThomasPKalavathyCJosephPAbrahamDItraconazole therapy for fungal keratitisIndian J Ophthalmol1987355–61571602854820
   PubMedGoogle Scholar
• SavaniDVPerfectJRCoboLMDurackDTPenetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitisAntimicrob Agents Chemother19873116103032091
   PubMed Web of Science ®Google Scholar
• Vanden BosscheHMackenzieDCauwenberghGAspergillus and AspergillosisNew York, NYPlenum Press Inc.1988
   Google Scholar
• JohnsonLKauffmanCVoriconazole: A new triazole antifungal agentClin Infect Dis200336563063712594645
   PubMed Web of Science ®Google Scholar
• HariprasadSMMielerWFHolzERDetermination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humansArch Ophthalmol20041221424714718293
   PubMedGoogle Scholar
• Vfend [Package insert]New York, NYPfizer Inc.32008
   Google Scholar
• KlontREgginkCRijsAWesselingPVerweijPSuccessful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazoleClin Infect Dis20054012e110e11215909252
   PubMed Web of Science ®Google Scholar
• GaoHPennesiMEShahKIntravitreal voriconazole: An electroretinographic and histopathologic studyArch Ophthalmol2004122111687169215534131
   PubMedGoogle Scholar
• TorresHHachemRChemalyRKontoyiannisDRaadIPosaconazole: A broad-spectrum triazole antifungalLancet Infect Dis200551277578516310149
   PubMed Web of Science ®Google Scholar
• UllmannAJCornelyOABurchardtAPharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infectionAntimicrob Agents Chemother200650265866616436724
   PubMed Web of Science ®Google Scholar
• SponselWEGraybillJRNevarezHLDangDOcular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitisBr J Ophthalmol200286782983012084760
   PubMed Web of Science ®Google Scholar
• TuEMcCartneyDBeattyRSpringerKLevyJEdwardDSuccessful treatment of resistant ocular fusariosis with posaconazole (SCH-56592)Am J Ophthalmol2007143222222717258521
   PubMed Web of Science ®Google Scholar
• Abdel-RahmanSNahataMOral terbinafine: A new antifungal agentAnn Pharmacother19973144454569101008
   PubMed Web of Science ®Google Scholar
• JensenJClinical pharmacokinetics of terbinafine (Lamisil)Clin Exp Dermatol19891421101132689012
   PubMed Web of Science ®Google Scholar
• NedelmanJRGibianskyERobbinsBPharmacokinetics and pharmacodynamics of multiple-dose terbinafineJ Clin Pharmacol19963654524618739024
   PubMed Web of Science ®Google Scholar
• LiangQFJinXYWangXLSunXGEffect of topical application of terbinafine on fungal keratitisChin Med J (Engl)2009122161884188819781365
   PubMed Web of Science ®Google Scholar
• GoldblumDFruehBESarraGMKatsoulisKZimmerliSTopical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit modelAntimicrob Agents Chemother20054941359136315793112
   PubMed Web of Science ®Google Scholar
• LalithaPShapiroBLSrinivasanMAntimicrobial susceptibility of fusarium, aspergillus, and other filamentous fungi isolated from keratitisArch Ophthalmol2007125678979317562990
   PubMedGoogle Scholar
• JurkunasULangstonDColbyKUse of voriconazole in the treatment of fungal keratitisInt Ophthalmol Clin2007472475917450006
   PubMedGoogle Scholar
• LevequeDNivoixYJehlFHerbrechtRClinical pharmacokinetics of voriconazoleInt J Antimicrob Agents200627427428416563707
   PubMed Web of Science ®Google Scholar
• Carrillo-MunozAQuindosGJLLRCurrent development in anti-fungal agentsCurr Med Chem200434297323
   Google Scholar
• BreitSHariprasadSMielerWShahGMillsMGrandMManagement of endogenous fungal endophthalmitis with voriconazole and caspofunginAm J Ophthalmol2005139113514015652837
   PubMed Web of Science ®Google Scholar
• GaoHPennesiMShahKSafety of intravitreal voriconazole: Electroretinographic and histopathologic studiesTrans Am Ophthalmol Soc200310118318914971576
   PubMedGoogle Scholar
• MarangonFMillerDGiaconiJAlfonsoEIn vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogensAm J Ophthalmol2004137582082515126145
   PubMed Web of Science ®Google Scholar
• NulensEEgginkCRijsAJMMWesselingPVerweijPEKeratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazoleJ Clin Microbiol20034152261226412734297
   PubMed Web of Science ®Google Scholar
• NochezYArseneSLe GuellecCUnusual pharmacokinetics of intravitreal and systemic voriconazole in a patient with Scedosporium apiospermum endophthalmitisJ Ocul Pharmacol Ther2008241879018370878
   PubMed Web of Science ®Google Scholar
• StewartAPowlesRHewetsonMAntrumJRichardsonCMehtaJCosts of antifungal prophylaxis after bone marrow transplantation. A model comparing oral fluconazole, liposomal amphotericin and oral polyenes as prophylaxis against oropharyngeal infectionsPharmacoeconomics19958435036110155676
   PubMed Web of Science ®Google Scholar
• DaviesNBiopharmaceutical considerations in topical ocular drug deliveryClin Exp Pharmacol Physiol200027755856210874518
   PubMed Web of Science ®Google Scholar
• UrttiAChallenges and obstacles of ocular pharmacokinetics and drug deliveryAdv Drug Deliv Rev200658111131113517097758
   PubMed Web of Science ®Google Scholar
• ForresterJVDickADRobertsFThe Eye: Basic Sciences in Practice: Basic Science in Practice2nd edLondon, UKSaunders Ltd2002
   Google Scholar
• KlotzSPennCNegveskyGButrusSFungal and parasitic infections of the eyeClin Microbiol Rev200013466268511023963
   PubMed Web of Science ®Google Scholar
• JtirvinenKUrttiAOcular absorption following topical deliveryAdv Drug Del Rev1995161319
   Web of Science ®Google Scholar
• SilveiraFPHusainSFungal infections in solid organ transplantationMed Mycol200745430532017510855
   PubMed Web of Science ®Google Scholar
• VemulakondaGAHariprasadSMMielerWFPrinceRAShahGKVan GelderRNAqueous and vitreous concentrations following topical administration of 1% voriconazole in humansArch Ophthalmol20081261182218195213
   PubMedGoogle Scholar
• DupuisATournierNLe MoalGVenisseNPreparation and stability of voriconazole eye drop solutionAntimicrob Agents Chemother200953279879919001119
   PubMed Web of Science ®Google Scholar
• SponselWChenNDangDTopical voriconazole as a novel treatment for fungal keratitisAntimicrob Agents Chemother200650126226816377696
   PubMed Web of Science ®Google Scholar
• ClodeADavisJSalmonJMichauTGilgerBEvaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horsesAm J Vet Res200667229630116454636
   PubMed Web of Science ®Google Scholar
• ThielMAZinkernagelASBurhenneJKaufmannCHaefeliWEVoriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitisAntimicrob Agents Chemother200751123924417060517
   PubMed Web of Science ®Google Scholar
• Al-BadriyehDLeungLRoydhouseTProspective open-label study of the administration of two-percent voriconazole eye dropsAntimicrob Agents Chemother20095373153315519433565
   PubMed Web of Science ®Google Scholar
• LauDPenetration of 1% voriconazole eye drops into human aqueous and vitreous humor – a prospective, open-label study (MClinPharm thesis)Melbourne, AustraliaMonash University2006
   Google Scholar
• FreemanPDKahookMYPreservatives in topical ophthalmic medications: Historical and practical review of benzalkonium chlorideExpert Rev Ophthalmol2009415964
   Google Scholar
• van der BijlPvan EykAMeyerDEffects of three penetration enhancers on transcorneal permeation of cyclosporineCornea200120550555811413407
   PubMed Web of Science ®Google Scholar
• SenguptaKKMikherjiREssentials Ocular Pharmacology and Therapeutics1st edKent, UKAnshan Pub.2007
   Google Scholar
• PolizziASiniscalchiCMastromarinoASaccaSEffect of voriconazole on a corneal abscess caused by fusariumActa Ophthalmol Scand200482676276415606478
   PubMedGoogle Scholar
• PratsCHTelloFLJoseABSOtaolaurruchiJSBainesJPOVoriconazole in fungal keratitis caused by Scedosporium apiospermumAnn Pharmacother200438341441714755065
   PubMed Web of Science ®Google Scholar
• ReisASundmacherRTintelnotKAgostiniHJensenHEAlthmausCSuccessful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazoleBr J Ophthalmol200084893293310979655
   PubMed Web of Science ®Google Scholar
• JonesAMuhtasebMUse of voriconazole in fungal keratitisJ Cataract Refract Surg200834218318418242428
   PubMed Web of Science ®Google Scholar
• Al-BadriyehDLeungLDaviesGEStewartKKongDSuccessful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of vatamycinAnn Pharmacother20094361139114219435962
   PubMed Web of Science ®Google Scholar
• Al-BadriyehDLeungLDaviesGEStewartKKongDSuccessful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitisAnn Pharmacother200943122103210719861430
   PubMed Web of Science ®Google Scholar
• Al-BadriyehDLiJStewartKStability of extemporaneously prepared voriconazole ophthalmic solutionAm J Health Syst Pharm200966161478148319667005
   PubMed Web of Science ®Google Scholar
• LauDLeungLFedinandsMPenetration of 1% voriconazole eye drops into human vitreous humour – a prospective, open-label studyClin Experiment Ophthalmol200937219720019723128
   PubMed Web of Science ®Google Scholar